Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo

Esophageal squamous cell carcinomas (ESCC) have become a severe threat to health and the current treatments for ESCC are frequently not effective. Recent epidemiological studies suggest that the anti-hyperglycemic agent metformin may reduce the risk of developing cancer, including ESCC, among diabet...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Xianbin, Hu, Xi, Tan, Xiaojun, Cheng, Weijie, Wang, Qinjia, Chen, Xiaofeng, Guan, Yinghong, Chen, Chong, Jing, Xubin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510392/
https://www.ncbi.nlm.nih.gov/pubmed/26196392
http://dx.doi.org/10.1371/journal.pone.0133349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510392/
https://www.ncbi.nlm.nih.gov/pubmed/26196392
http://dx.doi.org/10.1371/journal.pone.0133349

Ejemplares similares